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Autographa californica nucleopolyhedrovirus Ac16 is 1 of 17 genes conserved within Type 1 nucleopolyhedroviruses. This report
demonstrates that multiple isoforms of the protein encoded by Ac16, BV/ODV-E26 (E26), are present in the infected cell. One form of E26
associates with viral DNA or DNA-binding proteins, while a second form associates with intracellular membranes and this is likely due to
palmitoylation. The different forms of E26 present unique epitopes that can be discriminated by antiserum produced to bacterially or virally
produced antigen. A summation of the data now available on E26 suggests that it is a multifunctional protein and the functional states assume
unique conformations that can be discriminated by differing antisera.
© 2006 Elsevier Inc. All rights reserved.Keywords: Baculovirus; Membrane protein; PalmitoylationIntroduction
Knowledge of Autographa californica nucleopolyhedrovirus
(AcMNPV) orf 16 (Ac16) and its encoded protein includes
contradictory observations. There is general agreement that
Ac16 is an early gene and that transcripts accumulate rapidly
after infection. It was initially shown that Ac16 functioned in
conjunction with another early gene, da41, to stimulate late gene
expression (Guarino and Summers, 1988). However, this
observation was questioned when subsequent study revealed
that disrupting Ac16 did not delay the expression of other late
genes (O'Reilly et al., 1990). Based upon virus replication
assays performed in vitro and in insect larvae, O'Reilly et al.
(1990) suggested that Ac16 is non-essential, however this was
questioned when repeated attempts failed to isolate a null mutant
of the Bombyx mori homolog Bm8 (Imai et al., 2004; Kang et al.,
2005). Beniya et al. (1998) reported that Ac16 encoded a⁎ Corresponding author. Department of Entomology, College Station, TX
777843-2475, USA.
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doi:10.1016/j.virol.2006.11.007structural protein that is present in the envelopes of budded and
occlusion-derived virus (BVand ODV, respectively) and named
the gene product BV/ODV-E26 (E26). However, Imai et al.
(2004) did not detect Bm8 as a structural protein in progeny
virions, rather they showed that Bm8 encoded a protein that
accumulated in nuclear foci, co-localized with IE1 and bound
DNA.
The confusing results of these studies suggest several
possibilities: (i) even though the proteins encoded by the
homologous genes Ac16 and Bm8 (E26 and Bm8, respectively)
share 96% amino acid sequence identity, each functions in a
different capacity during infection by AcMNPVor BmNPV; (ii)
some aspects of previous studies and conclusions drawn of the
functional or structural roles of E26 or Bm8 are incorrect; or
(iii) E26 and Bm8 are multifunctional proteins and studies using
similar but different detection tools have unknowingly detected
different functional states. The goal of this study was to extend
our knowledge of the AcMNPV protein E26 and to resolve
some of the apparent discrepancies reported for the structure
and function of E26.
We show here that multiple isoforms of E26 are present in
the infected cell and the different isoforms present uniquely
195J.K. Burks et al. / Virology 361 (2007) 194–203different epitopes that are discriminated by antiserum produced
to bacterially or virally produced antigen. One form of E26
associates with viral DNA or DNA-binding proteins, while a
second form associates with intracellular membranes. E26
membrane association is likely mediated via palmitoylation.
Results
Ac16 is predominantly early but is also a late gene
While there is general agreement that Ac16 is expressed
early (Guarino and Summers, 1988; O'Reilly et al., 1990), it has
been suggested that transcripts for Ac16 are also present much
later in the temporal sequence of infection. To confirm this,
primer extension assays were performed early and late during
infection. Like previous results, transcripts initiating at −38 nt
were detected by 2 h p.i., increased in quantity between 6 and
18 h p.i. and were still present in decreased quantity through
72 h p.i. (Fig. 1A). Transcripts initiating near an upstream
CAGT sequence (−260 nt) were detected at maximal levels at
12 h p.i. (Fig. 1B). Two transcripts initiating from TAAG
sequences were detected at positions −783 and −838. One of
these transcripts (−838 nt) was detected as early as 6 h p.i.,
while the second transcript (−783 nt) was at maximal levels at
48 h p.i. (Fig. 1C). Both of the −783 and −838 transcripts
initiate within the Ac15 gene, yet the only ATG start codon
associated with an open reading frame of any length is that of
Ac16.
These data show that transcripts corresponding to Ac16 are
abundant between 6 and 12 h p.i. However, transcripts are alsoFig. 1. Primer extension analyses. Four transcripts were identified using primer exten
The placement of each of these transcripts relative to the DNA sequence and t
oligonucleotides used for the analyses is highlighted in gray.present late in infection (−38, −260, −783 and −838). Thus, it
is likely that E26 is synthesized both early and late during
infection.
Multiple isoforms of E26 are produced during infection
Antibodies are powerful and routine tools used for protein
detection. However, antibodies are themselves biological
reagents and their production is based upon a biological
response to dominant epitope presentation. With monoclonal
antibodies, it is common to generate antibodies that distinguish
between modified versions of the same protein. It is less
common to observe polyclonal antisera which detect unique
protein states, however if altered conformation results in
presentation of different dominant antigens, then polyclonal
antiserum may indeed distinguish between unique isoforms of
the same protein.
Published conclusions of E26 structure and function are
largely based upon antibody-generated results. One notable
difference in the production of these antisera is the source of the
Ac16 or Bm8 encoded protein antigen: BmNPV Bm8 was
amplified and purified from bacteria (Imai et al., 2004), whereas
AcMNPV E26 was amplified and purified from baculovirus
infected cells (Beniya et al., 1998). If Bm8 or E26 present
different dominant epitopes when produced in bacteria
compared to virus infection, and these dominant epitopes
reflect various functional states of the protein, then conclusions
based upon such selected antibody detection could explain
the conflicting conclusions reported for structure and function
of E26. We explored this possibility using several approaches:sion assays. These were detected at −38 (A), −260 (B) and −783 and −836 (C).
he methionine start codon of E26 is depicted in (D). The placement of the
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prepared by bacterial expression; (ii) removing the complexity
of antiserum altogether by tagging the E26 protein with a
unique antibody epitope; and (iii) comparing the profiles of
expression using the various antisera.
When AcMNPV-infected cell lysates were probed with the
Bm8 antibody (antigen expressed in bacteria), a unique
immunoreactive band at a molecular mass of 33 kDa was
detected (Fig. 2A; lanes 4 and 5). When the lysates were probed
with an equivalent E26 antibody (antibody #12500), a similar
immunoreactive protein was detected (Fig. 2A, lanes 7 and 8).
Thus, consistent results were obtained when comparable anti-
sera were used to probe infected cell extracts.
To remove the potential complexity of data imposed as a
result of using different E26 polyclonal antisera and to test if
virus infection modifies E26, Ac16 was fused with a sequence
encoding the amino acids comprising the T7 epitope (E26-T7;
T7 epitope adds 1 kDa of mass) and T7 antibody was used for
detection. When E26-T7 was transiently expressed in Sf9 cells,
a single immunoreactive band migrating at approximately
35 kDa was detected (Fig. 1A, lane 9). If, however, cells
transiently expressing E26-T7 were then infected with
AcMNPV, two proteins were detected; one of these is of a
molecular mass similar to that detected with both Bm8 and E26Fig. 2. E26 is modified during viral infection to 33 and 26 kDa isoforms. (A) Infected
antigen. The time post infection is noted above the gel. Lanes 3–5 were probed with a
E26. Lanes 9–10 show that, when produced in the absence of other viral protein (t
(T/E2), E26 migrates at 33 and 26 kDa. Lanes 9 and 10 were not loaded at equivalent
that result from infection. We also note that, while the cells were collected at 48 h p
infection was delayed and more likely represents a time point closer to 28–36 h p.i. (
virally produced E26 recognize the 26 kDa isoform of E26 (lanes 11–13; time post in
same Western blot showing that the 33 kDa isoform is present and recognized by th
present. (C) E26-T7polh recombinant virus was used to infect Sf9 cells (time post infec
lane noted as T (lane 17) represents an extract of Sf9 cells transiently expressing
substantially, especially in the regions of lower molecular weights, both Unstained
Markers (lane 2; both obtained from Promega) are shown for reference. The Mr assigantiserum #12,500 (33 kDa), while the second protein is at a
molecular mass of 26 kDa (Fig. 2A, lane 10). This result could
be due to several factors: (i) events occurring during virus
infection are uniquely modifying E26 in ways that affect its
migration pattern using SDS-PAGE; or (ii) the smaller forms of
E26 are the result of protein degradation.
If virus infection is producing modified forms of E26, it is
possible that the #7554 antiserum (generated to E26 purified
from infected cells) recognizes epitopes that are exposed as a
result of viral modification. When AcMNPV-infected cell
lysates were probed with #7554 antibody, the first immuno-
reactive protein detected (6 h p.i.) had a molecular mass of
26 kDa, similar to one of the AcMNPV-modified forms of E26-
T7 (Fig. 2B; compare lane 10 with lanes 12 and 13). With
increased exposure of the gel, it is clear that by 24 h p.i.
(compare lanes 13 and 14) immunoreactive bands with both
smaller and larger masses were also present in the infected cell
lysate and these include the 33 kDa form detected by Bm8 and
#12500 antisera (lanes 14 and 15). Considering that the 26 kDa
form of E26 was the first form detected during infection, and it
was present in the highest quantity throughout infection, we
consider it unlikely that it is the product of protein degradation.
Previous work has shown that, when E26 is produced under
the control of the polyhedrin promoter (E26polh), thus in highercell lysates were probed with two antisera produced to bacterially produced E26
ntiserum produced to BmNPV Bm8 while lanes 6–8 were probed with AcMNPV
ransient expression, (T)), E26 migrates at 35 kDa. If the cells are then infected
protein concentration, the important point of these data is the mass shifts of E26
.i., visible hallmarks of AcMNPV infection (occlusion production) suggest that
B) Cell lysates from AcMNPV-infected cells probed with antibody generated to
fection is noted above the gel). Lanes 14–15 show an increased exposure of the
e #7554 antiserum. Other forms of E26 with smaller molecular masses are also
tion is noted above the gel) and cell lysates were analyzed using T7 antibody. The
E26-T7 for reference. Considering that molecular weight markers can vary
Low Molecular Weight Markers (lane 1) and Pre-stained Precision Plus Blue
nments for the isoforms of E26 were determined using the unstained standards.
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type, E26 accumulates within the virogenic stroma (Beniya et
al., 1998). To determine if E26 produced under the control of
the polyhedrin promoter undergoes an apparent mass shift like
that observed during wild type infection (Fig. 2B, lanes 12–15),
cell lysates collected from a temporal course of infection by
E26-T7polh were probed with the T7 antibody. As expected,
polyhedrin-expressed E26-T7 was not detected early (6 h p.i.,
lane 18), but at 18 h p.i. E26-T7 was detected at a molecular
mass of 33 kDa. The smaller, 26 kDa form of E26 that is readily
detected in wild type AcMNPV-infected cells was not detected
until very late in infection, and even then only in small quantity
(lane 22). For reference, a sample of lysate prepared from Sf9
cells transiently expressing E26-T7 was included in the analysis
(Fig. 2C, lane 17 and lane 9 are comparable samples). These
results suggest that the temporal sequence of production and/or
quantity of E26 are somehow important for the modification(s)
of E26 that results in the mass shift to 26 kDa observed in wild
type infected cells.
These data show that antiserum generated to protein
produced in bacteria or virus-infected cells demonstrates a
marked difference in their ability to recognize the various forms
of E26. Antibodies generated to bacterially produced antigen
detect the higher molecular mass (33-kDa) form, whereas
antibodies produced to virally produced antigen have a high
affinity for the smaller, 26 kDa form.
We note that various molecular weight standards used for
SDS-PAGE generate different predictions of protein mass, and
this is shown in Fig. 2A. Lane 1 shows the migration pattern of
unstained standards, while lane 2 shows the corresponding
migration pattern of pre-stained standards (Biorad Low Range
and Precision Plus Blue, respectively). Throughout this study,
the apparent molecular weights were determined using the
unstained standards. Since molecular mass determination using
SDS-PAGE is a relative assignment, the molecular mass
assignment is less important than the relative shifts in molecular
mass detected for the various isoforms of E26.
E26 is palmitoylated and associates with membranes
It has been shown that E26 associates with membranes in
infected Sf9 cells (Braunagel et al., 2004; Saksena et al., 2004),
however previous results also suggest that E26 is not an integral
membrane protein (Beniya et al., 1998). Our continuing
experiments show that varying amounts of E26 fractionate
into detergent and aqueous phases depending upon the type and
concentration of detergent used for analyses (unpublished data).
When 1% Triton X-114 was used to extract infected cell lysates,
the 26 kDa form of E26 was detected only in the detergent phase
(Fig. 3A; lanes 3–10). Thus, these conditions were used for the
comparative analysis described in the next section.
Analysis of highly expressed E26 using the recombinant
viruses E26polh and E26-T7polh suggests that timing and
quantity of E26 produced during infection are not only
important for modification of E26 to the 26 kDa form but
also for localization in the cell (Fig. 2 and Beniya et al., 1998).
To identify if these alterations affect E26 membrane affinity,lysates of E26-T7polh infected cells were extracted with Triton
X-114. As expected by data shown in Fig. 2C, the dominant
form of E26 produced in cells infected with E26-T7polh was the
33 kDa isoform. A large amount of E26-T7 was detected in the
insoluble fraction and aqueous phase (Fig. 3A; lane 12 and 14),
while a smaller quantity fractionated into the detergent phase
(lane 13). Thus, in contrast to the results observed with E26
during wild type infection, when expressed in high quantity, a
substantial portion of E26 does not associate with membranes.
These results are consistent with immuno-electron microscopy
observations obtained with E26polh infected cells that show
that, in addition to its normal localization in intranuclear
microvesicles and ODV envelope, large quantities of E26
accumulate in the DNA-rich virogenic stroma (Beniya et al.,
1998).
To evaluate if infection is required for the membrane
association of E26, Sf9 cells transiently expressing E26-T7
were fractionated using Triton X-114. In these uninfected cells,
E26-T7 was only detected in the insoluble and aqueous
fractions (Fig. 3A, lanes 16 and 18) and was not observed in
the detergent fraction (lane 17). This strongly suggests that viral
infection is required to confer E26 with membrane association
properties.
Considering that E26 associates with the viral envelope
protein ODV-E66 (Braunagel et al., 2004), it is possible that E26
does not itself have an affinity for membranes, rather its
membrane association is mediated by interactions with other
viral proteins. To test this, radiolabeled E26 was translated in
vitro in the presence of microsomes prepared from uninfected or
AcMNPV-infected Sf9 cells. When translated in the presence of
Sf9-derived microsomes, E26 remained in the soluble fraction
and only a trace amount was detected in the microsomal
membrane pellet (Fig. 3B; lanes 1–3). A similar result was
obtained when E26was translated in the presence ofmicrosomes
derived from AcMNPV-infected cells (lanes 4–6). We conclude
from these results that E26 membrane affinity is not due to its
interaction with other cellular or viral membrane proteins.
Lipid anchored proteins frequently fractionate into both
aqueous and detergent phases depending upon the detergent
tested and stringency of experimental conditions. This is the
type of variability in results observed with E26 using various
detergent fractionation protocols (compare results obtained here
with previous results of Beniya et al., 1998). An analysis of the
amino acid sequence using the palmitoylation-predictor pro-
gram CSS-PALM (Zhou et al., 2006) reveals three cysteines that
have an increased probability to serve as palmitoylation
substrates (Fig. 4;★). To determine if E26 was palmitoylated,
cells were infected with AcMNPV, starved, supplemented with
3[H]-palmitate and precipitated using #7554 antibody (the
positive control gp64 was precipitated using mAb AcV1). The
result shows that E26 was labeled with 3[H]-palmitate (Fig. 3C;
lane 2) and the palmitoylated protein migrated at an apparent
molecular mass of 26 kDa.
We conclude that, under conditions of wild type infection,
the 26 kDa isoform of E26 has a high affinity for membranes
and this form is palmitoylated. However, the mass shift to
26 kDa is not a requirement for membrane association, the
Fig. 3. E26 membrane association properties are conferred during infection. (A) Cell extracts obtained at 24 and 48 h p.i. were extracted with Triton X-114 and
analyzed using Western blot probed with #7554 antibody (lanes 3–10). In lanes 11–14, 24 h p.i. extracts obtained from E26-T7polh infected cells were analyzed. Lanes
15–18 show an analyses of Sf9 cells transiently expressing E26-T7. The notations used are: CE=total cell extract; I= insoluble fraction; D=detergent fraction;
A=aqueous fraction. (B) E26 was translated in vitro using Sf9 derived microsomes (lanes 1–3) or AcMNPV-infected cell derived microsomes (lanes 4–8). After
translation, the sample was separated into the membrane pellet and soluble fraction, separated using SDS-PAGE and radiolabeled E26 visualized using
autoradiography. The notations used are: T=total translation mixture; S=soluble fraction; M=membrane pellet. (C) Infected cells were starved, supplemented with
3H-palmitate for 8 h and then precipitated using either preimmune antiserum (PI; lane 1), #7554 serum (E26; lane 2) or mAb AcV1 (gp64). The precipitated sample was
separated using SDS-PAGE, dried and labeled proteins visualized using autoradiography.
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demonstrates some, albeit limited, membrane affinity.
Deletion of domains within E26 alters its intracellular
localization
To identify domains within E26 essential for membrane
association and targeting to intranuclear membranes and ODV
envelope, two mutation constructs of E26 were generated. One
of these had the N-terminal 70 amino acids deleted (E2671–225),
while the second had the C-terminal 77 amino acids deleted(E261–148). Both mutants include the putative coiled-coil
domain (Fig. 4, underline), the basic region that also comprises
a predicted nuclear localization sequence (NLS; Fig. 4, yellow),
a putative amphipathic helix (Fig. 4, red dash) and an in-frame
C-terminal fusion of the amino acids comprising the epitope for
T7 antibody (Fig. 5A). For these experiments, we note that the
T7 antibody will only detect the truncated mutant protein,
however the E26 antibody #7554 should detect both mutant and
native E26.
The first approach was to transiently express each E26
construct in Sf9 cells, allow the cells to recover, infect with
Fig. 4. Amino acid sequences of E26 from various Type 1 NPVs. The nucleopolyhedroviruses listed in the lineup are: AcNPV—Autographa californica; RoNPV—
Rachiplusia ou; BmNPV—Bombyx mori; EpNPV—Epiphyas postvittana; OpNPV—Orgyia pseudotsugata; ApNPV—Antheraea peryni; CfNPV—Choristoneura
fumiferana; HcNPV—Hyphantria cunea.Various structural features of the E26 proteins are noted: the basic region that includes a nuclear localization-like sequence is
highlighted in yellow, a putative coiled-coil region is underlined and putative amphipathic helix is noted above the sequence with a red dashed line. Identical amino
acids are highlighted in dark gray, similar amino acids are highlighted with light gray. Highly conserved cysteines are highlighted in red, and the three cysteines that are
predicted to serve as substrates for palmitate are noted above the sequence with an asterisk.
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microscopy. When the E2671–225 mutant protein was tested,
antibodies #7554 and T7 detected proteins with significant co-
localization (Fig. 5B). Both antibodies detected proteins that
accumulated at the nuclear rim, within intranuclear foci and the
virogenic stroma. This result is in sharp contrast with that
obtained with E261–148. Deletion of the C-terminus of E26
resulted in the truncated protein locating predominantly to the
infected cell virogenic stroma (T7 antibody). Antibody #7554
detected wild type E26 in intranuclear foci of membrane
microvesicles with only marginal detection of the T7 fusion in
the virogenic stroma (Fig. 5B). Deletion of the C-terminal
77 amino acids appears to not only direct the truncated protein
to DNA-rich regions within the infected cell nucleus, with little
or no protein being directed to intranuclear membranes, but also
result in a protein conformation that is no longer recognized by
antibody #7554. The localization of E261–148 was similar to that
observed when analyzing the E26-βgal fusion protein produced
in the recombinant virus vDa26z (O'Reilly et al., 1990). In this
virus, the first 118 amino acids are fused to β-galactosidase
(noted in Fig. 4). Thus, like E261–148, the C-terminal region of
E26 is deleted in the E26-βgal protein. E26-βgal localized
exclusively within the virogenic stroma in infected cells
(Fig. 5C).
Previous results showed that when E26 was transiently
expressed (i.e. in the absence of other viral proteins) it was not
modified to lower molecular weight forms and it did not readily
associate with membranes. It was not a surprise then to observethat transiently expressed E26 was detected exclusively within
the nucleus (Fig. 5D).
The localization of E26 is altered during the temporal sequence
of AcMNPV infection
During AcMNPV infection, the location of E26 changes in a
reproducible, but temporally regulated fashion. Early in
infection (1–6 h p.i.), E26 was detected in punctate foci both
in the cytoplasm and nucleus (Fig. 5E). Previous analysis using
immuno-electron microscopy has shown that these foci
represent both electron dense, chromatin-like regions and
membrane vesicles (Beniya et al., 1998). At approximately 8–
12 h p.i., E26 localized in a more generalized pattern within
DNA-rich regions in the nucleus, and a number of the
observations included E26 accumulating in intranuclear foci
(Fig. 5E). This pattern of localization resembles that previously
reported for Bm8 in cells infected with BmNPV (Imai et al.,
2004). At approximately 16 h p.i., the dominant localization
pattern of E26 changed again; E26 was now detected in smaller
quantity within the DNA-rich regions of the virogenic stroma
and increased immunofluorescence now associated with
cytoplasmic and nuclear membranes, along with foci of viral-
induced intranuclear membrane microvesicles (Fig. 5E and
Beniya et al., 1998). By 18 h p.i., E26 located almost
exclusively in foci of viral-induced microvesicles within the
nucleus (Fig. 5E), and this pattern remained constant throughout
infection. These temporally regulated differences in protein
Fig. 5. Immuno-confocal microscopy analyses of E26 and E26 derivatives. (A) Notable motifs within E26 are noted, NLS=nuclear localization sequence;
C=cysteines predicted to serve as substrates for palmitate modification. E2671–225 is a derivative that has the N-terminal 70 amino acids deleted and E261–148 has the
C-terminal 77 amino acids deleted. Both truncation derivatives are fused at the C-terminus with the amino acids comprising the epitope for T7 antibody. (B) Cells
transiently expressing each derivative were infected with AcMNPVand then analyzed using immuno-confocal microscopy. The truncation derivative of E26-T7 was
detected using the T7 antibody, whereas native E26 was detected using #7554 antiserum. The substantial co-localization pattern of T7 and #7554 antibody (merge)
shows that the E2671–225 derivative is recognized by both of these antisera, whereas #7554 antiserum did not recognize the E261–148 derivative. Location of the nucleus
and DNA-rich regions was detected using DAPI stain. We note that while the cells were collected at 48 h p.i. visible hallmarks of AcMNPV infection (occlusion
production) suggest that infection was delayed, and a visual overview of the cell population suggests that infection represents a time point closer to 28–36 h p.i. The
delay and lack of viral occlusions are shown in the bright field image. (C) A 48 h p.i. sample of cells infected with the mutant virus vDa26z was analyzed using
antibody to β-galactosidase. (D) Sf9 cells transiently expressing E26 were analyzed using #7554 antibody. The antibody to insect lamin Dm0 (Adl67) was used to note
the nuclear periphery. (E) Sf9 cells were infected with AcMNPVand then analyzed at various times post infection. Antibody #7554 was used to detect E26 and DAPI
was used to identify the nucleus and DNA-rich regions.
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consistent with the idea that E26 performs multiple activities
throughout the temporal sequence of infection.
Discussion
Currently, the role and function of Ac16 and its encoded
protein, E26, are an enigma. The Ac16 gene is only present in
about half of the sequenced and annotated baculoviruses and
one would expect that such a poorly conserved gene could
easily be deleted from the genome. However, Ac16 is 1 of the
17 genes conserved within the genomes of Type 1 NPVs
(Herniou et al., 2003). Repeated attempts by ourselves and
others have failed to generate an Ac16-null virus. These
observations strongly suggest that, within the Group 1 NPVs,
Ac16 provides an essential function.
E26 is targeted to different locations within the infected cell
in a temporally regulated fashion. We speculate that the
targeting of E26 is controlled through regulated protein
modification events, and our observations show that these
modification(s) alter apparent molecular mass, properties of
membrane association and protein destination. In the absence of
other viral proteins, E26 has an apparent molecular mass of
35 kDa, is soluble, locates in the cell nucleus and has an affinity
for DNA-rich regions. In contrast, during AcMNPV infection,
at least two forms of E26 are present and these are uniquely
recognized by various antibody preparations. One form
migrates at 26 kDa, is palmitoylated and readily associates
with cellular membranes. This form is predominantly recog-
nized by antiserum #7554, which was generated to E26 purified
from infected cells. A second form of E26 migrates at 33 kDa
and this form is recognized by antiserum generated to
bacterially produced E26 (Bm8 and #12500). Considering
that these antisera only detect E26 associated with the cell
nucleus and co-localizing with IE1 (Imai et al., 2004), it appears
that this isoform has the greater affinity for DNA or DNA-
binding proteins.
Many of the previous and current conclusions about E26 are
based upon results generated using antibody probes. The data
presented here strongly suggest that the specificity of the
antibody preparations varies depending upon the source of E26
antigen. We now know that E26 is modified during infection,
and it is not unrealistic to conclude that modification(s) that
result in such substantial alterations of biological properties
would also alter immunogenic epitope presentations.
E26 binds to IE1 and this activity is essential
While there remains an incomplete understanding of the
molecular events that confer unique properties to E26, certain
cohesive elements of E26 structure and function are emerging.
Current data strongly suggest that the N-terminal region of E26
provides an essential function and contains the binding site for
IE1 (Kang et al., 2005). One early study suggested that Ac16
could easily be mutated, however we now understand that the
essential N-terminal domain was retained within the genome of
this recombinant virus. Indeed, this domain has been retained inboth reported E26 mutant viruses: vDa26z and BmD8 (O'Reilly
et al., 1990; Imai et al., 2004). Since these viruses appear to
retain the essential activity of E26, then the early observation
that E26 functions to regulate late gene expression may still be
valid. E26 may function in an essential role during viral DNA
replication of Group 1 NPVs.
When E26 is transiently expressed in Sf9 cells (absence of
other viral proteins), it accumulates within the nucleus (Fig. 5D)
and fractionates in the aqueous and insoluble, DNA-rich
fraction. These data suggest that one important function of
E26 is performed in relationship with DNA and this function
occurs in the absence of other viral proteins. Considering that
the antisera generated to bacterially produced E26 appear to
preferentially recognize the DNA-binding, soluble form of E26,
we conclude that this form does not require viral modification to
be active.
E26 has a second functional activity that is associated with
membranes
Previously published data clearly show that E26 associates
with ER membranes and that it associates with the viral inner
nuclear membrane sorting motif (INM-SM) derived from ODV-
E66 (Braunagel et al., 2004). The data presented here are
consistent with a membrane-associated function of E26 and
clearly suggest that infection is responsible for post-transla-
tional events that support its membrane association. By 24 h
p.i., a substantial amount of E26 fractionates with the detergent
Triton X-114. One explanation for this affinity may be the post-
translational covalent linkage with palmitate. Biochemically,
palmitoylation enhances the surface hydrophobicity of protein
substrates and promotes their interactions with membranes
(Kleuss and Krause, 2003). Palmitoylation is a reversible lipid
modification (Linder and Deschenes, 2003; Dietrich and
Ungermann, 2004) that can regulate intracellular trafficking
and sorting (Kang et al., 2004; Schneider et al., 2005),
subcellular localization (Van Itallie et al., 2005) and functional
activity (Sudo et al., 1992). As such, palmitoylation alone could
explain the dynamic alterations of E26 that result in apparent
molecular mass shifts, membrane association properties or
different subcellular localizations.
Predicting cysteine substrates for palmitoylation is a process
that is not well defined. The common denominator for most
palmitoylated cysteines is the presence of a membrane targeting
sequence that consists of positive charges, adjacent lipid
anchors or transmembrane domains (Dietrich and Ungermann,
2004). Programs designed to predict cysteine substrates that
have a high likelihood of serving as palmitate substrates are
emerging, and one such program, CSS-PALM (Zhou et al.,
2006), predicts three cysteines within E26 that have an
increased probability of serving as substrate for palmitoylation.
The cysteine at position 128 scores the highest in this analysis
(Fig. 4; red star). When E26 mutants are analyzed, the mutant
containing an N-terminal truncation (E2671–225) retains these
cysteines and results show that it is still targeted to mem-
branes, although an increased amount of E26 protein is also
targeted to DNA-rich regions (Fig. 5B). However, when two
202 J.K. Burks et al. / Virology 361 (2007) 194–203of the cysteines are deleted (E261–148), the mutant E26 protein
is now only detected in DNA-rich regions (Fig. 5B). This
result is consistent with the idea that one of these three
cysteines serves as the substrate for the covalent linkage of
palmitate. If palmitoylation results in altering the conformation
of E26, then this could also explain some of the properties of
the various antibodies. Antiserum generated to viral-derived
antigen (#7554) only demonstrates a limited ability to
recognize E26 derivatives that lack the C-terminal portion of
the protein (Fig. 5B, E261–148), however it recognizes both the
26 and 33 kDa isoform of the mature protein. Antiserum
generated to bacterially produced antigen (non-palmitoylated
source) does not recognize the 26 kDa, membrane-associated
form of E26. An understanding of the characteristics of these
antibodies provides substantial insight into understanding the
complexity and seemingly contradictory observations of the
structure and function of E26.
A summary of the data suggests that E26 fulfills specific
needs of Group 1 NPVs in three important viral activities: (i) to
optimize viral DNA replication by binding to DNA and DNA-
binding proteins; (ii) enhance late gene transcription in
association with Ac15; and (iii) facilitate the trafficking of
ODV envelope proteins from their site of insertion in the ER
toward the nuclear envelope and virus induced intranuclear
membranes (Braunagel et al., 2004; Saksena et al., 2004, 2006).
We conclude from these studies that E26 is a multifunctional
protein that assumes more than one functional conformation
within the infected cell. In order to develop a comprehensive
understanding of E26, additional studies directed toward
understanding each of these functional activities will be
required.
Materials and methods
Cell culture, recombinant virus and transient expression
Spodoptera frugiperda (Sf9) cells were cultured as described
in Summers and Smith (1987). A. californica nucleopol-
yhedrovirus (E2 strain) was used at a multiplicity of infection
of 20. Recombinant virus was generated using the technique
described in Summers and Smith (1987) and PCR was used to
confirm legitimate recombination in the polyhedrin gene locus.
To express the genes under the control of the IE1 promoter for
transient expression, constructs were cloned into the plasmid
pIE1-4 (Novagen). Plasmid DNAwas transfected into Sf9 cells
using the calcium phosphate method described in Summers and
Smith (1987). After transfection, cells were allowed to recover
for 48 h. At this time, cells were either prepared for microscopy
or infected with virus.
Antibody production
Production of the E26 antiserum #7554 was described in
Beniya et al. (1998). Before use, this serum was preadsorbed
with agarose-bound GST-E25 and GST-FP25K. After adsorp-
tion, no cross-reactivity to these or other viral proteins was
detected. For Western blot analysis, preadsorbed #7554 serumwas used at a dilution of 1:20,000. Antiserum #12500 was
produced to a pMAL-E26 fusion protein. BL21 cells were
transformed with the pMal-E26 fusion plasmid, induced with
IPTG and mal-E26 was purified using maltose resin. Rabbits
were injected with antigen 4 times at 28-day intervals, and
serum was collected 14 days after the last injection. To remove
cross-reactivity to cellular proteins, Sf9 cells were sequentially
fixed in 3.7% paraformaldehyde and methanol, permeabilized
with 0.5% Triton X-100 and washed. The serum preparation
was diluted 500-fold in blocking solution (PBS, pH 7.2, 1%
normal chicken serum) and incubated with the fixed, per-
meabilized cells for 1 h. The supernatant was collected and
residual cell debris removed by centrifugation. Cross-reaction
with cellular proteins was removed using this treatment, and
serum was used at 1:1000 in Western blot analysis. T7
antibody (Novagen) was used at a 1:10,000 dilution. The Bm8
antiserum was kindly provided by I. Imai and used at a dilution
of 1:1000.
Palmitoylation assay
The technique of Zhang et al. (2003) was used to label
infected cells with 3[H]-palmitate. Briefly, Sf9 cells were
infected with AcMNPV and, at 34 h p.i., the cells were
transferred from complete media to Grace's media (minus fetal
bovine serum) for 1.5 h. Cells were returned to complete media
and incubated with 3[H]-palmitate (500 μCi) for 8 h. Cells were
then collected, lysed and incubated with antiserum #7554,
preimmune serum or mAb AcV1. The antibody bound protein
was enriched using Protein A/G agarose, proteins were
separated using SDS-PAGE, gel was dried and labeled proteins
visualized using autoradiography.
Primer extension
Transcripts were mapped using strand-specific oligonucleo-
tides and standard primer extension techniques using Super-
script II (Sambrook et al., 1989). Transcript initiation sites were
identified by running the primer extension product concurrent
with a DNA sequence reaction using the same oligonucleotide
primer on the denaturing gel routinely used for DNA se-
quencing reactions.
Immuno-confocal microscopy
Cells were processed for light microscopy using procedures
described in Braunagel et al. (1999). Briefly, cells were
collected, fixed with 3.7% paraformaldehyde and followed by
methanol fixation (10 min each). Cells were treated with 0.5%
Triton X-100 and rinsed with PBS. Cells were blocked with
1% normal goat or chicken serum and 3% BSA. Primary
antibody was incubated overnight (4 °C), washed and then
incubated with secondary antibody for 1 h (room temp). When
DAPI (4′-6-diamidino-2-phenylindole; 0.1 μg/ml) was used,
cells were treated with DAPI for 5 s and washed. The antibodies
and concentrations used were: lamin (Stuurman et al., 1995;
1:250), E26 #7554 (1:1000), T7 antibody (Novagen; 1:1000)
203J.K. Burks et al. / Virology 361 (2007) 194–203and β-galactosidase antibody (Sigma; 1:1000). Cells were
viewed and photographed with a Zeiss Axiovert 135 micro-
scope with a CARV confocal module. Images were collected at
0.75-μm intervals using Zeiss AXIOVISION 3.1 software.
Detergent fractionation
Treatment with Triton X-114 (1%) was performed using the
method of Bordier (1981). As a control, the separated samples
were tested for the fractionation profiles of marker proteins: the
detergent phase contained the envelope proteins ODV-E66 and
ODV-E25 while p39 and FP25K fractionated into the aqueous
phase.
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